Author

A. Huber

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1 Pharmacology & Toxicology· 1 Zoology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

A. Barrera· 1 shared A. Benke· 1 shared A. Bousssioutas· 1 shared A. D. Sandor· 1 shared A. Gonzalez Manjon· 1 shared A. H. Allam· 1 shared A. Morocz· 1 shared A. Nemeth· 1 shared

Activity by Year

2019-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Barrera

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

In vitro genotoxic and mutagenic potentials of combustion particles from marine fuels with different sulfur contents

S. Jeong, J. Pantzke, S. Offer, U. Kaefer, J. Bendl, M. Saraji-Bozorgzad, A. Huber, B. Michalke, U. Etzien, G. Jacobi, J. Orasche, H. Czech, C. P. Rueger, J. Schnelle-Kreis, T. Streibel, , R. Zimmermann

This study evaluates the genotoxic and mutagenic effects of combustion particles from marine fuels with varying sulfur content, finding that toxicological outcomes correlate more with polycyclic aromatic hydrocarbon content than sulfur content.

bioRxiv · Jun 27, 2024Pharmacology & Toxicology

Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within Interleukin-6 family cytokines

A. Huber, A. H. Allam, C. Dijkstra, S. Thiem, J. Huynh, A. R. Poh, J. Konecnik, S. P. Jacob, R. Busuttil, Y. Liao, D. Chasinga, W. Shi, M. G. Alorro, S. Forrow, D. V. F. Tauriello, , M. F. Eissmann

This study identifies IL6/STAT3 signaling as a therapeutic target for TP53-mutant gastric cancer by showing its role in metastatic progression driven by mutant Trp53.

bioRxiv · Apr 22, 2024Cancer Biology

Ornithological and molecular evidence of a reproducing Hyalomma rufipes population under continental climate in Europe

G. Keve, T. Csorgo, A. Benke, A. Huber, A. Morocz, A. Nemeth, B. Kalocsa, E. A. Tamas, J. Gyuracz, O. Kiss, D. Kovats, A. D. Sandor, Z. Karcza, S. Hornok

This study identifies an autochthonous Hyalomma rufipes population in Europe, found on non-migratory birds during nesting, with genetic evidence of local reproduction and distinct tick species distribution across regions.

bioRxiv · Jan 13, 2023 · PreprintZoology

The SPIRE1 actin nucleator coordinates actin/myosin functions in the regulation of mitochondrial motility

F. Straub, T. Welz, H. Alberico, R. O. Brandao, A. Huber, A. Samol-Wolf, C. Brakebusch, D. Woods, M. Kollmar, J. Martin-Gonzalez, E. Kerkhoff

This study shows that SPIRE1 regulates mitochondrial motility by targeting myosin 5 and formin to mitochondria, inhibiting their movement.

bioRxiv · Jun 19, 2020 · PreprintCell Biology

Glucocorticoids regulate cancer cell dormancy

S. Prekovic, K. Schuurman, A. Gonzalez Manjon, M. Buijs, I. Mayayo Peralta, M. D. Wellenstein, S. Yavuz, A. Barrera, K. Monkhorst, A. Huber, B. Morris, C. Lieftink, J. Silva, B. Györffy, L. Hoekman, , W. Zwart

This study identifies the mechanism by which glucocorticoid receptor activation induces cancer cell dormancy through CDKN1C and FOXO1/IRS2 signaling, with implications for cancer therapy.

bioRxiv · Sep 4, 2019 · PreprintCancer Biology